These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16076297)

  • 1. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.
    Wagenmann M; Schumacher L; Bachert C
    Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors contributing to nasal allergic late phase eosinophilia.
    Kramer MF; Jordan TR; Klemens C; Hilgert E; Hempel JM; Pfrogner E; Rasp G
    Am J Otolaryngol; 2006; 27(3):190-9. PubMed ID: 16647984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2.
    Wagenmann M; Baroody FM; Desrosiers M; Hubbard WC; Ford S; Lichtenstein LM; Naclerio RM
    Clin Exp Allergy; 1996 Apr; 26(4):371-8. PubMed ID: 8732233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of nasal cytology in atopic patients after nasal allergen challenge.
    Wang D; Clement P; De Waele M; Derde MP
    Rhinology; 1995 Jun; 33(2):78-81. PubMed ID: 7569656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of nasal hyper-responsiveness by allergen challenge in allergic rhinitis: the role of afferent and efferent nerves.
    Sheahan P; Walsh RM; Walsh MA; Costello RW
    Clin Exp Allergy; 2005 Jan; 35(1):45-51. PubMed ID: 15649265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of IL-6, IL-8, and GM-CSF release in nasal secretions of allergic patients after nasal challenge.
    Ohkubo K; Ikeda M; Pawankar R; Gotoh M; Yagi T; Okuda M
    Rhinology; 1998 Dec; 36(4):156-61. PubMed ID: 9923057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis.
    Benson M; Wennergren G; Fransson M; Cardell LO
    Int Arch Allergy Immunol; 2004 Jul; 134(3):227-32. PubMed ID: 15178892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intranasal azelastine on the response to nasal allergen challenge.
    Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM
    Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal CpG oligodeoxynucleotide administration induces a local inflammatory response in nonallergic individuals.
    Månsson A; Bachar O; Adner M; Cardell LO
    Allergy; 2009 Sep; 64(9):1292-300. PubMed ID: 19243360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of TNFalpha on the human nasal mucosa in vivo.
    Widegren H; Korsgren M; Andersson M; Greiff L
    Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis].
    Tahamiler R; Saritzali G; Canakçioğlu S
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):30-6. PubMed ID: 17483609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levels of interleukin-4, interleukin-5, tryptase and eosinophil cationic protein of nasal lavage fluid in pollen allergic rhinitis].
    Rapp J; Kósa L; Halász A; Kereki E; Börzsönyi L
    Orv Hetil; 2000 Aug; 141(35):1919-22. PubMed ID: 11019593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-13 is essential to the late-phase response in allergic rhinitis.
    Miyahara S; Miyahara N; Matsubara S; Takeda K; Koya T; Gelfand EW
    J Allergy Clin Immunol; 2006 Nov; 118(5):1110-6. PubMed ID: 17088137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge.
    Sim TC; Grant JA; Hilsmeier KA; Fukuda Y; Alam R
    Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):339-44. PubMed ID: 8306027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
    Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mediators in late antigen-induced rhinitis.
    Naclerio RM; Proud D; Togias AG; Adkinson NF; Meyers DA; Kagey-Sobotka A; Plaut M; Norman PS; Lichtenstein LM
    N Engl J Med; 1985 Jul; 313(2):65-70. PubMed ID: 2582257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.